Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.8150 (5.13%) ($8.8150 - $8.8500) on Mon. Jul. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.66% (three month average) | RSI | 47 | Latest Price | $8.8150(5.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 1.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(67%) ARKG(64%) IBB(57%) IWC(49%) ARKK(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.83% in a week (0% probabilities). EDOC(-32%) TBT(-24%) UUP(-15%) VXX(-5%) VIXM(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.83% (StdDev 5.66%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.41(4.82%) | 10 Day Moving Average | $8.31(6.08%) | 20 Day Moving Average | $8.68(1.56%) | To recent high | -23.3% | To recent low | 38.7% | Market Cap | $547m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |